Nihon M&A Center (2127) Q4 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2026 earnings summary
4 May, 2026Executive summary
Celebrated 35th anniversary and marked recovery from FY 2021 accounting incident, entering a new growth phase called Next GENESIS and launching Vision 300 targeting ¥30bn ordinary profit by FY2032.
Achieved double-digit growth in sales and profit for FY2025, with sales at ¥50,257 million (+14.0% YoY) and ordinary profit at ¥19,154 million (+13.2% YoY), surpassing mid-term targets a year early.
Regained original performance cycle, achieving 80% of annual targets by Q3 and strong momentum for FY2026.
Introduced a trust-type stock compensation plan to align management and employee interests with shareholders, pending approval.
Equity-method affiliate Batonz Co., Ltd. listed on TSE Growth Market in April 2026.
Financial highlights
FY2025 sales: ¥50,257 million (+14.0% YoY); ordinary profit: ¥19,154 million (+13.2% YoY); net profit: ¥12,515 million (+14.1% YoY); operating profit: ¥18,761 million (+12.2% YoY).
Number of transactions closed: 1,061 (down 1.6% YoY); M&A sales per transaction: ¥45.7 million (+15.4% YoY); large transactions (fees >¥100mn): 115 (+45.6% YoY).
Cost of sales: ¥19.9 billion (+15% YoY); SG&A: ¥11.5 billion (+15% YoY).
Net assets/shareholder equity: ¥50,643 million as of March 2026; total assets: ¥66,223 million.
Cash and cash equivalents at period end: ¥39,440 million.
Outlook and guidance
FY2026/FY2027 guidance: sales ¥52,800 million (+5.1% YoY), ordinary profit ¥19,300 million (+0.8% YoY), net profit ¥13,400 million (+7.3% YoY).
Vision 300 aims for ordinary profit of ¥30 billion by FY2032, with business domain expansion in funds, overseas, and PMI.
Dividend per share to remain at ¥29, with a payout ratio above 60% and special dividend components.
Latest events from Nihon M&A Center
- Sales and profit fell, but record new mandates and strong forecasts signal future growth.2127
Q3 20253 Feb 2026 - Record new mandates and strong profit margins support growth despite industry challenges.2127
Q2 20253 Feb 2026 - Q1 sales and profits fell, but strong mandates and investments support a positive outlook.2127
Q1 20252 Feb 2026 - Record sales, profits, and margins drive positive outlook and special dividend.2127
Q3 20262 Feb 2026 - Record Q4 profit, cautious outlook, focus on quality, compliance, and new growth pillars.2127
Q4 202529 Nov 2025 - Q1 sales and profits surged, margins improved, and guidance remains strong with a special dividend.2127
Q1 202616 Nov 2025 - H1 FY2025 saw strong profit and sales growth, margin gains, and a special dividend planned.2127
Q2 20263 Nov 2025